1921
Volume 103, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

COVID-19 represents the greatest health challenge of modern years. The spectrum of illness comprises respiratory and non-respiratory manifestations. We report the case of an adult man with COVID-19 who presented with rhabdomyolysis as a principal extrapulmonary manifestation. Our patient presented with dyspnea, fever, and muscle pain. After a comprehensive approach, the diagnosis of COVID-19 and rhabdomyolysis was made. He developed acute kidney injury requiring renal replacement therapy without reversibility, despite optimal treatment. We performed a literature search for similar cases, discuss the potential mechanisms implied, and propose a diagnostic-therapeutic algorithm.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.20-0692
2020-07-29
2020-09-28
Loading full text...

Full text loading...

/deliver/fulltext/14761645/103/3/tpmd200692.html?itemId=/content/journals/10.4269/ajtmh.20-0692&mimeType=html&fmt=ahah

References

  1. Worldometer.Info, 2020. Coronavirus Cases: 2020 July 15. USA (Delaware). Available at: https://www.worldometers.info/coronavirus/. Accessed July 15, 2020.
    [Google Scholar]
  2. Weng L et al., 2020. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 8: 506517.
    [Google Scholar]
  3. Chavez LO, Leon M, Einav S, Varon J, 2016. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care 20: 135.
    [Google Scholar]
  4. Khan F, 2009. Rhabdomyolysis: review of the literature. Neth J Med 67: 272283.
    [Google Scholar]
  5. Crum-Cianflone NF, 2008. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 21: 473494.
    [Google Scholar]
  6. Jin M, Tong Q, 2020. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis 26: 16181620.
    [Google Scholar]
  7. Suwanwongse K, Shabarek N, 2020. Rhabdomyolysis as a presentation of 2019 novel coronavirus disease. Cureus 12: e7561.
    [Google Scholar]
  8. Zhang Q, Shan KS, Minalyan A, O’Sullivan C, Nace T, 2020. A rare presentation of coronavirus disease 2019 (COVID-19) induced viral myositis with subsequent rhabdomyolysis. Cureus 12: e8074.
    [Google Scholar]
  9. Chan KH, Farouji I, Abu Hanoud A, Slim J, 2020. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19). Am J Emerg Med 38: 1548.e11548.e3.
    [Google Scholar]
  10. Guan WJ et al., 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 18: 17081728.
    [Google Scholar]
  11. Chen L-L, Hsu C-W, Tian Y-C, Fang J-T, 2005. Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. Int J Clin Pract 59: 11621166.
    [Google Scholar]
  12. Saad M et al., 2014. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 301306.
    [Google Scholar]
  13. Desdouits M, Munier S, Prevost M-C, Jeannin P, Butler-Browne G, Ozden S, Gessain A, Werf SVD, Naffakh N, Ceccaldi P-E, 2013. Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A (H1N1) viruses. PLoS One 8: e79628.
    [Google Scholar]
  14. Nunes Duarte-Neto A et al., 2020. Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy. Histopathology. Available at: https://doi.org/10.1111/his.14160.
    [Google Scholar]
  15. Wang JL et al., 2003. Rhabdomyolysis associated with probable SARS. Am J Med 115: 421422.
    [Google Scholar]
  16. Heyne N, Guthoff M, Weisel KC, 2009. Rhabdomyolysis and acute kidney injury. N Engl J Med 361: 1412.
    [Google Scholar]
  17. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G, 2020. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97: 829838.
    [Google Scholar]
  18. Batlle D et al., 2020. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol 31: 14.
    [Google Scholar]
  19. Ronco C, Reis T, 2020. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol 16: 308310.
    [Google Scholar]
  20. Su H et al., 2020. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98: 219227.
    [Google Scholar]
  21. Petejova N, Martinek A, 2014. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care 18: 224.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.20-0692
Loading
/content/journals/10.4269/ajtmh.20-0692
Loading

Data & Media loading...

  • Received : 17 Jun 2020
  • Accepted : 22 Jul 2020
  • Published online : 29 Jul 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error